Diseases, Conditions, Syndromes

Large market share for non-quality-assured malaria medicines in Africa

A new study of malaria medicine quality in 8 sub-Saharan African countries has found a large and potentially growing market for non-quality-assured (QA) malaria treatments—medicines not pre-approved by global health organisations ...

Medications

After harsh light, a cheaper version of EpiPen from Mylan

Mylan is releasing a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew scorn from parents nationwide and spawned Congressional inquiries.

Medications

New research predicts market share for drug makers

Lagging behind in launching new medicines means a much smaller market share for pharmaceutical companies—even if they spend just as much on advertising, according to new research from Duke University's Fuqua School of Business.

Health

Fonterra slammed over botulism scare response

New Zealand dairy giant Fonterra bungled its response to a food contamination scare because it was more concerned with market share than public safety, an official inquiry found Tuesday.

Health

E-cigarettes: growing, but fragmented $3 bn market

The World Health Organization took aim Tuesday at e-cigarettes, the increasingly popular, ostensibly safer tobacco substitute which WHO nevertheless says poses a serious threat to young people.

page 3 from 4